Radiobiology Annelie E. Meijer.

Slides:

Advertisements

Similar presentations

MedAustron – Austrian Hadron Therapy Centre

Advertisements

HEPTECH meeting at Sofia Overview of Technology Marketing at GSI.

Some remaining questions in particle therapy radiation biology Bleddyn Jones University of Oxford 1. Gray Institute for Radiation Oncology & Biology 2.

Radiation Therapy (RT). What is cancer? Failure of the mechanisms that control growth and proliferation of the cells Uncontrolled (often rapid) growth.

Tumour Therapy with Particle Beams Claus Grupen University of Siegen, Germany [physics/ ] Phy 224B Chapter 20: Applications of Nuclear Physics 24.

Voltage-Gating in Synthetic Nanopores Induced by Cobalt Ions Michael Sullivan, Undergraduate: George Mason University IM SURE Fellow, 2006 Dr. Zuzanna.

Study of the fragmentation of Carbon ions for medical applications Protons (hadrons in general) especially suitable for deep-sited tumors (brain, neck.

Dose, Biological Effects, and Exposure Models

TRAINING COURSE ON RADIATION DOSIMETRY: Radiobiology Basics – RBE, OER, LET Anthony WAKER University of Ontario Institute of Technology Thu. 22/11/2012,

BIOLOGICAL EFFICIENCY OF A THERAPEUTIC PROTON BEAM: A STUDY OF HUMAN MELANOMA CELL LINE I. Petrović 1, A. Ristić-Fira 1, D. Todorović 1, L. Korićanac 1,

Heavy Ion Tumor Therapy

A (Quick) Survey of (Some) Medical Accelerators Dr. Todd Satogata Brookhaven National Laboratory SUNY Stony Brook PHY 684 – September 5, 2007  The NASA.

Report from WP4: Applications of Accelerators AccApplic  Accelerator Applications  Aims of WP4  Workshops so far  Future workshops  Status  Plans.

Using CERN Technologies for Medical Applications Steve Myers Director of Accelerators and Technology, Geneva, Switzerland 12th June 2013, 1.

The Skandion clinic, plans for the use of particle beams for radiation therapy in Sweden presented by Erik Grusell, medical radiation physicist Dept of.

PAMELA Contact Author: CONFORM is an RCUK-funded Basic Technology Programme Charged Particle Therapy Treating cancer with protons and light ions Ken Peach,

INTRODUCTION : Imaging antiprotons INTRODUCTION : Imaging antiprotons First results of real time imaging of the high energy gamma rays coming from antiproton.

A Laser Afternoon: Introduction Ken Peach Particle Therapy Cancer Research Institute (Oxford Martin.

MARIE SKŁODOWSKA-CURIE ACTIONS Innovative Training Networks : H2020 “MEDICIS-produced radioisotope beams for medicine”

Medical requirements for FFAG as proton beam sources Jacques BALOSSO, MD, PhD Radiation oncologiste UJF / INSERM / ETOILE FFAG 2007, April 12-17, 2007.

TREATMENT PLANNING Modelling chemo-hadron therapy Lara Barazzuol | Valencia | 19 June 2009.

First Year Workshop 2014 Miriam Lafiandra

08 November 2006ENLIGHT++ for KnowARC project1 ENLIGHT ++ Proton and Ion Therapy “e”-infrastructure for health; “e” for “enhanced, enabled, excellent”

M. Silari - The ARDENT ITN project 1CNAO, Pavia, 19 October 2012 ARDENT February 2012 – January 2016 Advanced Radiation Dosimetry European Network Training.

The Increased Biological Effectiveness of Heavy Charged Particle Radiation: From Cell Culture Experiments to Biophysical Modelling Michael Scholz GSI Darmstadt.

The Magic Cube and the Pixel Ionization Chamber: detectors for monitor and dosimetry of radiotherapy beams S. Amerio 1, A. Boriano 2, F. Bourhaleb 2,3,

24 September 2008 ENLIGHT, ESF Workshop-Oxford European Network for Light Ion Therapy ENLIGHT Manjit Dosanjh ENLIGHT Coordinator & CERN.

Response of the sensors to different doses from tests in Israel Radiotherapy is used as a treatment in around 50% of cancer cases in the UK. Predominantly,

ENLIGHT Meeting Novel Imaging Systems WP1: Time-of-flight in-beam PET (TERA, INFN, IFIC/CSIC, IN2P3, OncoRay, CERN, PoliAnnecy, Oxford) WP2: In-beam single.

ENLIGHT- PARTNER Meeting, June 2009, IFIC- Valencia Manjit DOSANJH ENLIGHT Coordinator & CERN.

CERN Medical Applications Steve Myers Head of CERN Medical Applications Former Director of Accelerators and Technology CERN, Geneva.

2010 Student Practice in JINR Fields of Research

Applications of particle accelerators outside particle physics Ken Peach APPEAL 2 Oxford 2 nd July 2011.

ARDENT Advanced Radiation Dosimetry European Network Training initiative WP1: Gas Detectors S. Rollet.

October 16thPicosecond Lyon1 INNOTEP Project Using HEP technologies to improve TEP imaging: Development of innovative schemes for front-end electronic,

March 2011 CERN, Geneva European Training Network for Particle Therapy Founded by the European Commission PARTNER.

USE OF GEANT4 CODE FOR VALIDATION OF RADIOBIOLOGICAL PARAMETERS OBTAINED AFTER PROTON AND CARBON IRRADIATIONS OF MELANOMA CELLS Ivan Petrović 1, Giuseppe.

TPS & Simulations within PARTNER D. Bertrand, D. Prieels Valencia, SPAIN 19 JUNE 2009.

Present & Future of Accelerators for Hadrontherapy A. Faus-Golfe IFIC-IFIMED June 20091IFIMED'09 Symposium.

The Use of Accelerator Beams for Calibration and Characterization of Solid State Nuclear Track Detectors Eric Benton Department of Physics Oklahoma State.

Cern.ch/knowledgetransfer. Knowledge Transfer | Accelerating Innovation BE-KT Innovation Day,

Comparison of MC and TP Dosimetry Simulations for Cancer Treatment Raymond Mumme May 12, 2014 Supervisor: Thiago Lima (PhD student) Head Supervisor: Dr.

Radiotherapy Physics Chris Fox Department of Physical Sciences Peter MacCallum Cancer Centre.

Hartmut Eickhoff, GSI 1 Developments in Hadrontherapy -the role of Basic Research Institutes H. Eickhoff GSI/Darmstadt.

Scientific, Technological and Industrial Applications June 20091IFIMED'09 Symposium.

WP4: Applications of Accelerators AccApplic  WP4: Applications of Accelerators  The applications  Current workshops  Future workshops  Plans EuCARD-2.

The Australian Hadron Therapy and Research Facility.

HADRONTHERAPY IN ROMANIA NICOLAE IOAN VERGA M.D., Ph.D., D.Sc. “CAROL DAVILA” UNIVERSITY OF MEDICINE AND PHARMACY, ROMANIAN SOCIETY OF HADRONTHERAPY BUCHAREST,

Hadron Radiotherapy Pavel Kundrát Institute of Physics, Academy of Sciences of the Czech Republic, Prague

Particle Therapy at GSI

AccMed Accelerators for Medicine

Proposal for a new INFN experiment

Radiological Protection in Ion Beam Radiotherapy

Combined effect of charged particles irradiation and anticancer drugs in cultured tumor cells.(RDH_IRPT WP2; INFN_Milano, CNAO and Istituto Tumori) The.

Access to material testing facilities (WP10)

New and Emerging fields in Bio-medicine

EURADOS Working Group 9: Radiation Dosimetry in Radiotherapy

MeV Ion Microbeams and Radiation Biology at the University of Surrey

CELLION Technical Report

Johannes Leidner, Fabrizio Murtas, Marco Silari

CLIC-Spain collaboration report

Presented by : José F. Salt Cairols

AQUA-ADVANCED QUALITY ASSURANCE FOR CNAO

Welcome !! to the Conference on Beam Diagnostics

HST Medical Applications

Design of a PET-isotope-based hadron therapy facility

CERN The world’s largest Particle Physics Research Center in Geneva

Giulio Magrin, TERA Foundation, Manjit Dosanjh, ENLIGHT++, CERN

Figure 5 The biological effects of charged particles

Innovations in the Radiotherapy of Non–Small Cell Lung Cancer

Presentation transcript:

Radiobiology Annelie E. Meijer

Collaborating Institutes Number of researchers CERN, European Organization for Nuclear Research (Coordinator) 4ESR Fondazione CNAO (IT) 2ESR +2ER GSI, Gesellschaft für Schwerionenforschung (DE) 2ESR HIT, Heidelberg Ion Therapy Inc (DE) 3ER Karolinska Institutet (SE) 3ESR University of Surrey, (GB) 2 ESR TERA Foundation (IT) IBA, Ion Beam Applications (BE) MedAustron (AT) 1 ESR Siemens Medical Solutions (DE) Associated Partners ETOILE Project (FR) IFIC, IFIMED Project (ES) ESR- Early stage researcher, ER- Experienced Researcher

Characteristics of light-ion beams; measurements of depth-dose profiles (Bragg curves), lateral scattering, fragmentation characteristics, and including these data into the TRiP Supervisors: Dieter Schardt Michael Krämer Marco Durante Giovanna Martino

Biological effectiveness of light and heavy ions on clonogenic cell survival and measurements of the RBE in dependence on energy, LET and OER Supervisors: Wilma Kraft-Weyrather Marco Durante Walter Tinganelli

Comparative analysis of cellular and molecular responses of cancer and normal cells towards high and low LET radiation Supervisors: Margareta Edgren Annelie Meijer Anders Brahme Chitraleka Mohanty

Katarzyna Zielinska-Chomej Modelling of different types of radiation-induced cell deaths following exposures to low linear energy transfer (LET) photons and high LET accelerated ions Supervisors: Margareta Edgren Annelie Meijer Anders Brahme Katarzyna Zielinska-Chomej

Effects of different ion species, nano-beams and chemotherapy in combination with radiation exposures on cell survival Chew Ming Tsuey Supervisors: Karen Kirkby Norman Kirkby

Effects of ion species, nanobeams on cell survival Mathematical modelling and investigation of chemotherapy in combination with radiotherapy and hadron therapy. Effects of ion species, nanobeams on cell survival Supervisors: Karen Kirkby Norman Kirkby Raj Jena Lara Barazzuol

Detectors and Accelerators

Collaborating Institutes Number of researchers CERN, European Organization for Nuclear Research (Coordinator) 4ESR Fondazione CNAO (IT) 2ESR +2ER GSI, Gesellschaft für Schwerionenforschung (DE) 2ESR HIT, Heidelberg Ion Therapy Inc (DE) 3ER Karolinska Institutet (SE) 3ESR University of Surrey, (GB) 2 ESR TERA Foundation (IT) IBA, Ion Beam Applications (BE) MedAustron (AT) 1 ESR Siemens Medical Solutions (DE) Associated Partners ETOILE Project (FR) IFIC, IFIMED Project (ES) ESR- Early stage researcher, ER- Experienced Researcher

Application of PET imaging in light ion therapy Supervisors: Anders Brahme Iuliana Toma-Dasu Johanna Kempe Marta Lazzeroni

Design of the linac for the carbon ion cyclinac proposed by TERA Supervisors: Ugo Amaldi Angeles Faus-Golfe Silvia Verdú Andrés

Beam instrumentation Javier Alabau Supervisors: Angeles Faus-Golfe

Thank you for your attention!